n-methyl-3,4-methylenedioxyamphetamine has been researched along with Recrudescence in 12 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-four patients presenting with first-ever seizure within 24 h of illicit use of amphetamine or related analogs (amphetamine-associated seizures, AAS) were identified over 8 years." | 7.77 | Amphetamine-associated seizures: clinical features and prognosis. ( Brown, JW; Dunne, JW; Fatovic, DM; Fatovich, DM; Lawn, ND; Lee, J, 2011) |
| " Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg." | 3.78 | Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. ( Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC, 2012) |
| "Forty-four patients presenting with first-ever seizure within 24 h of illicit use of amphetamine or related analogs (amphetamine-associated seizures, AAS) were identified over 8 years." | 3.77 | Amphetamine-associated seizures: clinical features and prognosis. ( Brown, JW; Dunne, JW; Fatovic, DM; Fatovich, DM; Lawn, ND; Lee, J, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Karimi-Haghighi, S | 1 |
| Mahmoudi, M | 1 |
| Sayehmiri, F | 1 |
| Mozafari, R | 1 |
| Haghparast, A | 1 |
| Wang, LJ | 1 |
| Chen, MY | 1 |
| Lin, CY | 1 |
| Chong, MY | 1 |
| Chou, WJ | 1 |
| You, YH | 1 |
| Tsai, CP | 1 |
| Chen, YS | 1 |
| Lu, SF | 1 |
| Ogeil, RP | 1 |
| Rajaratnam, SM | 1 |
| Broadbear, JH | 1 |
| Downey, LA | 1 |
| Loftis, JM | 1 |
| Brown, JW | 1 |
| Dunne, JW | 1 |
| Fatovich, DM | 1 |
| Fatovic, DM | 1 |
| Lee, J | 1 |
| Lawn, ND | 1 |
| Ball, KT | 2 |
| Slane, M | 1 |
| Russell, T | 1 |
| Riazi, S | 1 |
| Kraeva, N | 1 |
| Steel, AC | 1 |
| Hawryluck, LA | 1 |
| Walsh, KM | 1 |
| Rebec, GV | 1 |
| Sadeghian, S | 1 |
| Darvish, S | 1 |
| Shahbazi, S | 1 |
| Mahmoodian, M | 1 |
| Hamilton, J | 1 |
| Balint, P | 1 |
| Field, M | 1 |
| Sturrock, RD | 1 |
| Pallanti, S | 1 |
| Mazzi, D | 1 |
| McCann, UD | 1 |
| Ricaurte, GA | 1 |
2 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Recrudescence
| Article | Year |
|---|---|
Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies.
Topics: Amphetamine; Animals; Cannabinoid Receptor Antagonists; Central Nervous System Stimulants; Cocaine; | 2023 |
Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Energy Metabolism; | 2014 |
10 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Recrudescence
| Article | Year |
|---|---|
Difference in long-term relapse rates between youths with ketamine use and those with stimulants use.
Topics: Adolescent; Central Nervous System Stimulants; Child; Excitatory Amino Acid Antagonists; Female; Hum | 2018 |
Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
Topics: Adult; Affect; Amphetamine-Related Disorders; Female; Guilt; Hallucinogens; Humans; Male; Mental Hea | 2013 |
Amphetamine-associated seizures: clinical features and prognosis.
Topics: Adolescent; Adult; Amphetamine; Anticonvulsants; Central Nervous System Stimulants; Electroencephalo | 2011 |
Differential involvement of prelimbic and infralimbic medial prefrontal cortex in discrete cue-induced reinstatement of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Operant | 2012 |
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System St | 2012 |
Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues.
Topics: Animals; Conditioning, Operant; Cues; Extinction, Psychological; Hallucinogens; Injections, Intraven | 2007 |
Two ecstasy-induced myocardial infarctions during a three month period in a young man.
Topics: Adult; Fatal Outcome; Hallucinogens; Humans; Male; Myocardial Infarction; N-Methyl-3,4-methylenediox | 2007 |
A concealed cause of recurrent renal failure in a patient with juvenile chronic arthritis.
Topics: Adult; Amphetamines; Arthritis, Juvenile; Hallucinogens; Humans; Kidney Failure, Chronic; Male; N-Me | 1999 |
MDMA (Ecstasy) precipitation of panic disorder.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Agoraphobia; Alcohol Drinking; Amitriptyline; Arousal; Fluvoxa | 1992 |
MDMA ("ecstasy") and panic disorder: induction by a single dose.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal; | 1992 |